Literature DB >> 29688333

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

H Kadara, M Choi, J Zhang, E R Parra, J Rodriguez-Canales, S G Gaffney, Z Zhao, C Behrens, J Fujimoto, C Chow, Y Yoo, N Kalhor, C Moran, D Rimm, S Swisher, D L Gibbons, J Heymach, E Kaftan, J P Townsend, T J Lynch, J Schlessinger, J Lee, R P Lifton, I I Wistuba, R S Herbst.   

Abstract

Entities:  

Year:  2018        PMID: 29688333      PMCID: PMC6887935          DOI: 10.1093/annonc/mdx062

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

1.  Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients.

Authors:  Suwei Wang; Xiaoqing Yuan; Yazhen Liu; Kewei Zhu; Peng Chen; Han Yan; Daoyu Zhang; Xi Li; Hui Zeng; Xielan Zhao; Xiaoping Chen; Gan Zhou; Shan Cao
Journal:  J Transl Med       Date:  2019-03-28       Impact factor: 5.531

2.  Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From Gprc5a-Deficient Murine Lung Adenocarcinoma With Somatic Kras Mutations.

Authors:  Reem Daouk; Maya Hassane; Hisham F Bahmad; Ansam Sinjab; Junya Fujimoto; Wassim Abou-Kheir; Humam Kadara
Journal:  Front Oncol       Date:  2019-04-02       Impact factor: 6.244

Review 3.  Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment.

Authors:  Sara Saab; Hussein Zalzale; Zahraa Rahal; Yara Khalifeh; Ansam Sinjab; Humam Kadara
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

4.  Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer.

Authors:  Qiang Wang; Danting Zhou; Fang Wu; Qingchun Liang; Qiongzhi He; Muyun Peng; Tianyu Yao; Yan Hu; Banglun Qian; Jingqun Tang; Xiang Wang; Wenliang Liu; Fenglei Yu; Chen Chen
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

5.  Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma.

Authors:  Lilan Yi; Ping Huang; Yinfang Gu; Guowu Wu; Xiaofang Zou; Longhua Guo; Chunling Wen; Junlin Zhu; Dongdong Zhao
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

6.  Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma.

Authors:  Qin Hu; Runtian Wang; Huiyun Ma; Zhouwei Zhang; Qun Xue
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

7.  Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma.

Authors:  Dong-Hu Yu; Jing-Yu Huang; Xiao-Ping Liu; Xiao-Lan Ruan; Chen Chen; Wei-Dong Hu; Sheng Li
Journal:  Oncol Lett       Date:  2019-12-09       Impact factor: 2.967

Review 8.  The Resistance Mechanisms of Lung Cancer Immunotherapy.

Authors:  Fen Wang; Shubin Wang; Qing Zhou
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.